Boehringer Ingelheim has been reorganized in Spain. The pharmaceutical company has introduced three new managers to its human health franchise. The aim is to “prepare for the challenges of the future and respond in a more agile manner to the needs of patients,” the company said in a statement.
The three new managers are Oscar Ibarra, Mohamed Sammy and David Wolters, who, in addition to leading the human health sector, are part of the company’s pharmaceutical committee.
Specifically, these three areas are, on the one hand, an entity focused on adding value to patients suffering from cardiometabolic diseases, on the other hand, a franchise dedicated to tackling rare and complex pathologies and the entity in charge of the so-called “mature products” and innovative Management of projects. Each franchise has teams in the areas of marketing, pharmaceutical and market access, while the areas of communications, public affairs, legal, human resources or finance continue to provide cross-cutting support.
Boehringer has selected Oscar Ibarra, Mohamed Sammy and David Wolters for these three positions.
Ibarra, after eight years at Boehringer Ingelheim, takes over as head of the franchise, which focuses on adding value to the patients who live with Cardio-metabolic diseases, such as type 2 diabetes, heart failure and chronic kidney disease, among others. After graduating in Pharmacy, Ibara strengthened her skills by doing an MBA in Esic and training in Management at ISE. Thereafter, he developed his professional career at Novartis and Sanofi, holding positions of responsibility in the commercial, medical and access departments. Later, in 2014, he joined Boehringer Ingelheim as . got included in regional customer manager for, subsequently, to assume the office of the Director of the Department of customer facing of the company
Sammy takes over as head of franchise dedicated to addressing complex pathologyFrom rare diseases such as idiopathic pulmonary fibrosis (IPF) or minor dermatological diseases to oncological diseases that require hospitalized medications.
To date, Sammy has held various positions in the company abroad. Her training in pharmacy inspired her to start her professional career as a sales representative at GlaxoSmithKline (GSK) and later Merck in 2008. In 2009 he joined Boehringer Ingelheim in Saudi Arabia. medical scientist liaison And during his later years he held various functions in both sales and marketing.
Wolters holds the position of head of the franchise in charge of the so-called “mature products”. and the management of innovative projects of a digital nature, which allows the customer experience to be transformed through a variety of channels, data and services.
Wolters has held various positions both in Spain and abroad. After graduating in Business Administration in the Netherlands, he strengthened his skills by completing a Master’s degree in Economics from the University of Amsterdam and an MBA from Esed. All this to them. inspired to take on the role of Area of Rare Diseases Europe Ed in Novartis.